ResMed (RMD) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $228.35 -0.37%
EPS Growth %: +5.5%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.5%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, $0.01 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $406.29 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
- Dell’s earning report was bullish for Intel CPU demand, analyst says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
